Change in Connectivity After mTBI Depending on Cognitive Reserve

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the role of cognitive reserve in change in connectivity in the brain (measured with functional magnetic resonance imaging, fMRI) and how this is related to symptoms and symptom resolution.

Clinical Trial Description

The population-based rate of mild traumatic brain injury (mTBI) is estimated to exceed 600/100000 population per year in total, if including only patients seeking emergency care the estimated rate is approximately 100-300/100000. Many patients recover within 3 months after injury but a sustainable proportion suffer from persisting symptoms, for instance fatigue, headaches, irritability. As conventional neuroimaging techniques have failed to detect the subtle alterations that may be important for prognosis and long-term outcome after mTBI, studies using fMRI have shown some interesting results. Other variables, for instance demographic and cognitive variables, also need to be incorporated with imaging biomarkers when investigating the relationship between fMRI biomarkers with outcome after mTBI. A marker related to demographic status and cognition that have shown to be relevant for outcome in brain injury or pathology is cognitive reserve. Cognitive reserve is defined as an aspect of the brain's function or structure that impacts the relationship between injury/pathology and outcome. Higher cognitive reserve is related to better outcome in conditions ranging from Alzheimer, MS and mTBI. In this study 15 patients with mTBI and 15 patients with minor orthopedic injury underwent assessment, including cognitive testing, self-assessment of symptoms, testing of visual functions and resting-state fMRI at approximately one week after injury and 4 months after injury. Cognitive reserve was assessed with a lexical decision test designed to measure pre-morbid IQ. Descriptive statistics will be used to depict demographics, injury characteristics, results on neuropsychological tests and psychological screening instruments. Multi-subject and multi-session analysis based on general linear model will be performed and assessed using statistical tools including regression analysis and 2-way ANOVA. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05593172
Study type	Observational
Source	Danderyd Hospital
Contact
Status	Completed
Phase
Start date	January 24, 2015
Completion date	May 3, 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04372797` - Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI)	N/A
Completed	`NCT01903525` - DHA For The Treatment of Pediatric Concussion Related to Sports Injury	Phase 1
Completed	`NCT01847040` - Deployment Related Mild Traumatic Brain Injury (mTBI)
Completed	`NCT03678077` - Trends in Cohabitation Status, Academic Achievement and Socio-economic Indicators After Mild Traumatic Brain Injury
Recruiting	`NCT05682677` - Combined Neuromodulation and Cognitive Training for Post-mTBI Depression	N/A
Terminated	`NCT03345550` - OPTIMA-TBI Pilot Study	Phase 2
Completed	`NCT05095012` - RECOVER Clinical Pathway for Pediatric Concussion	N/A
Recruiting	`NCT05886400` - The Effects of Environmental Distractions on SCAT6 Outcomes	N/A
Recruiting	`NCT05262361` - Persistent Post-Concussion Symptoms With Convergence Insufficiency	N/A
Active, not recruiting	`NCT03892291` - Objective Dual-task Turning Measures for Return-to-duty Assessments
Completed	`NCT03688984` - Treatment of Insomnia for Adolescents With Mild Traumatic Brain Injury	N/A
Completed	`NCT02057081` - Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI	N/A
Recruiting	`NCT06233851` - t-BIOMAP : Prospective Paediatric Cohort Study of Blood Biomarkers in mTBI
Completed	`NCT02844946` - One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology	N/A
Completed	`NCT04641767` - BIOmarkers of TRAumatic Brain Injury Spain (BIOTRABIS)
Recruiting	`NCT06112093` - Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches	N/A
Recruiting	`NCT03819608` - Neuromodulation and Neurorehabilitation for mTBI Plus PTSD	N/A
Withdrawn	`NCT00580918` - Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients
Completed	`NCT03319966` - Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
Recruiting	`NCT03846830` - Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.